| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mk-2461 | fibroblast growth factor receptor 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | phase 1/2 | inhibitor |
| mk-2461 | fibroblast growth factor receptor 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | phase 1/2 | unknown |
| mk-2461 | fibroblast growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | phase 1/2 | unknown |
| mk-2461 | fibroblast growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | phase 1/2 | inhibitor |
| mk-2461 | fibroblast growth factor receptor 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | phase 1/2 | inhibitor |
| mk-2461 | fibroblast growth factor receptor 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | phase 1/2 | unknown |
| mk-2461 | vegfr1 messenger rna | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | phase 1/2 | inhibitor |
| mk-2461 | fms-like tyrosine kinase 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | phase 1/2 | inhibitor |
| mk-2461 | fms-like tyrosine kinase 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | phase 1/2 | unknown |
| mk-2461 | vascular endothelial growth factor receptor 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | phase 1/2 | inhibitor |
| mk-2461 | vascular endothelial growth factor receptor 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | phase 1/2 | unknown |
| mk-2461 | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | phase 1/2 | inhibitor |
| mk-2461 | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | phase 1/2 | unknown |
| mk-2461 | tyrosine-protein kinase mer | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.52 | phase 1/2 | inhibitor |
| mk-2461 | tyrosine-protein kinase mer | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.52 | phase 1/2 | unknown |
| mk-2461 | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | phase 1/2 | unknown |
| mk-2461 | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | phase 1/2 | inhibitor |
| mk-2461 | macrophage-stimulating protein receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.35 | phase 1/2 | unknown |
| mk-2461 | macrophage-stimulating protein receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.35 | phase 1/2 | inhibitor |
| mk-2461 | bdnf/nt-3 growth factors receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | phase 1/2 | unknown |
| mk-2461 | bdnf/nt-3 growth factors receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | phase 1/2 | inhibitor |
| mk-2461 | nt-3 growth factor receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | phase 1/2 | unknown |
| mk-2461 | platelet-derived growth factor receptor beta | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.12 | phase 1/2 | inhibitor |
| mk-2461 | platelet-derived growth factor receptor beta | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.12 | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||